| 2024 | Effect of the peripartum depressive symptoms on the Internet use disorder of their offspring in late childhood: retrospective longitudinal study
| SCIENTIFIC REPORTS |
| 2023 | Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in <i>FGFR</i>-altered breast cancer
| SCIENTIFIC REPORTS |
| 2023 | Association between changes in having of cancer patients in the family and depression: A longitudinal panel study
| JOURNAL OF AFFECTIVE DISORDERS |
| 2023 | 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib
| COMMUNICATIONS BIOLOGY |
| 2023 | Estimating causal effects with hidden confounding using instrumental variables and environments
| Electronic Journal of Statistics |
| 2023 | A unified mediation analysis framework for integrative cancer proteogenomics with clinical outcomes
| BIOINFORMATICS |
| 2022 | A Bayesian precision medicine framework for calibrating individualized therapeutic indices in cancer | ANNALS OF APPLIED STATISTICS |
| 2022 | Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes | HEPATOLOGY |
| 2022 | CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts
| SCIENTIFIC REPORTS |
| 2022 | Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study | INTERNATIONAL JOURNAL OF CANCER |
| 2022 | TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model
| COMMUNICATIONS BIOLOGY |
